Literature DB >> 11809524

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.

Asima Chakraborty1, Adelheid Brantner, Teruo Mukainaka, Yoshitoshi Nobukuni, Masashi Kuchide, Takao Konoshima, Harukuni Tokuda, Hoyoku Nishino.   

Abstract

Achyranthes aspera leaves have been assessed for chemopreventive activity. The MeOH extract, alkaloid, non-alkaloid and saponin fractions exhibited significant inhibitory effects (concentration 100 microg) on the Epstein-Barr virus early antigen activation induced by the tumor promotor 12-O-tetradecanoylphorbol-13-acetate in Raji cells. In this in vitro assay the non-alkaloid fraction containing mainly non-polar compounds showed the most significant inhibitory activity (96.9%; 60% viability). In the in vivo two-stage mouse skin carcinogenesis test the total methanolic extract possessed a pronounced anticarcinogenic effect (76%). The present study suggests that A. aspera leaf extract and the non-alkaloid fraction are valuable antitumor promotors in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809524     DOI: 10.1016/s0304-3835(01)00766-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  Antineoplastic and immunomodulatory effect of polyphenolic components of Achyranthes aspera (PCA) extract on urethane induced lung cancer in vivo.

Authors:  Chandradeo Narayan; Arvind Kumar
Journal:  Mol Biol Rep       Date:  2013-11-05       Impact factor: 2.316

3.  Larvicidal activity of saponin from Achyranthes aspera against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae).

Authors:  A Bagavan; A A Rahuman; C Kamaraj; Kannappan Geetha
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

4.  Amelioration effects against N-nitrosodiethylamine and CCl(4)-induced hepatocarcinogenesis in Swiss albino rats by whole plant extract of Achyranthes aspera.

Authors:  R Kartik; Ch V Rao; S P Trivedi; P Pushpangadan; G D Reddy
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

5.  Comparison of plants used for skin and stomach problems in Trinidad and Tobago with Asian ethnomedicine.

Authors:  Cheryl Lans
Journal:  J Ethnobiol Ethnomed       Date:  2007-01-05       Impact factor: 2.733

6.  Therapeutic Effect of Saponin Rich Fraction of Achyranthes aspera Linn. on Adjuvant-Induced Arthritis in Sprague-Dawley Rats.

Authors:  Pankaj S Kothavade; Vipin D Bulani; Dnyaneshwar M Nagmoti; Padmini S Deshpande; Nitin B Gawali; Archana R Juvekar
Journal:  Autoimmune Dis       Date:  2015-07-26

7.  Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats.

Authors:  Naveed Khan; Muhammad Shoaib Akhtar; Barkat Ali Khan; Valdir de Andrade Braga; Adam Reich
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

Review 8.  Plants used to treat skin diseases.

Authors:  Nahida Tabassum; Mariya Hamdani
Journal:  Pharmacogn Rev       Date:  2014-01

9.  Comparing and phylogenetic analysis chloroplast genome of three Achyranthes species.

Authors:  Jingya Xu; Xiaofeng Shen; Baosheng Liao; Jiang Xu; Dianyun Hou
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

Review 10.  Indigenous medicinal plants of Pakistan used to treat skin diseases: a review.

Authors:  Amber Sharif; Hira Asif; Waqas Younis; Humayun Riaz; Ishfaq Ali Bukhari; Asaad Mohamed Assiri
Journal:  Chin Med       Date:  2018-10-19       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.